Kodiak Sciences Inc KOD:NASDAQ

Last Price$9.02Cboe Previous Close - Real-Time Last Sale as of 4:01PM ET 6/24/22
Cboe Real-Time Quotes
Today's Change0(0.00%)
Bid (Size)$8.65 (4)
Ask (Size)$9.00 (1)
Day Low / HighN/A - N/A
Volume1.9 M
 

View Biotechnology IndustryPeer Comparison as of 06/24/2022

 

Kodiak Sciences Inc ( NASDAQ )

Price: $9.02
Change: -0.02 (0.22%)
Volume: 1.9 M
4:01PM ET 6/24/2022
 
 

Bionano Genomics Inc ( NASDAQ )

Price: $1.62
Change: +0.07 (4.52%)
Volume: 13.1 M
4:00PM ET 6/24/2022
 
 

Vaxart Inc ( NASDAQ )

Price: $3.78
Change: +0.09 (2.44%)
Volume: 5.1 M
4:00PM ET 6/24/2022
 
 

Radius Health Inc ( NASDAQ )

Price: $10.11
Change: -0.73 (6.73%)
Volume: 5.3 M
4:00PM ET 6/24/2022
 
 

Mersana Therapeutics Inc ( NASDAQ )

Price: $5.00
Change: +0.09 (1.83%)
Volume: 5.3 M
4:00PM ET 6/24/2022
 

Read more news Recent News

--Goldman Sachs Adjusts Price Target for Kodiak Sciences to $5 From $7, Reiterates Neutral Rating
11:12AM ET 5/24/2022 MT Newswires

Price: 6.49, Change: -0.36, Percent Change: -5.26 ...

Morgan Stanley Lowers Kodiak Sciences' Price Target to $10 From $12, Maintains Equalweight Rating
12:28PM ET 5/17/2022 MT Newswires

Kodiak Sciences (KOD) has an average rating of outperform and price targets ranging from $5 to $75, according to analysts polled by Capital IQ. (MT...

--Berenberg Bank Adjusts Kodiak Sciences' Price Target to $24 From $27, Maintains Buy Rating
7:30AM ET 5/13/2022 MT Newswires

(MT Newswires covers equity, commodity and economic research from major banks and research firms in North America, Asia and Europe. Research providers may...

-- Earnings Flash (KOD) KODIAK SCIENCES Posts Q1 Loss $-1.83
4:36PM ET 5/10/2022 MT Newswires

...

Company Profile

Business DescriptionKodiak Sciences, Inc. is a clinical-stage biopharmaceutical company. The firm engages in the development of novel therapies for the treatment of retinal diseases. Its product pipeline includes KSI-301 for wet AMD, KSI-301 for diabetic eye disease, KSI-501 for DME and uveitis, KSI-201 for resistant wet AMD, and KSI-401 for dry AMD. The company was founded by Stephen A. Charles and Victor Perlroth in 2009 and is headquartered in Palo Alto, CA. View company web site for more details
Address1200 Page Mill Road
Palo Alto, California 94304
Phone+1.650.281.0850
Number of Employees28
Chairman & Chief Executive OfficerVictor Perlroth
Chief Financial Officer & Senior Vice PresidentJohn A. Borgeson
Chief Medical & Development OfficerJason S. Ehrlich
Chief Information OfficerMichael S. Louie

Company Highlights

Price Open$9.05
Previous Close$9.04
52 Week Range$4.90 - 131.97
Market Capitalization$468.6 M
Shares Outstanding52.0 M
SectorHealth Technology
IndustryBiotechnology
Next Earnings Announcement08/08/2022

Options Summary

Call Open Interest (1d)*
Put Open Interest (1d)*
Call Volume (1d)*
Put Volume (1d)*
Put Call Open Interest Ratio (1d)*
Put Call Volume Ratio (1d)*
* Data delayed by up to 15 minutes

View all fundamentalsFundamentals

Price / EarningsN/A
Earnings per Share-$6.01
Beta vs. S&P 500N/A
Revenue$0.00
Net Profit MarginN/A
Return on Equity-45.15%

Analyst Ratings as of 06/09/2022

Buy
5
Overweight
0
Hold
4
Underweight
0
Sell
1
Consensus RecommendationConsensus Icon
Powered by Factset